Literature DB >> 18500478

[Randomised controlled trials].

Philipp Mad1, Rosemarie Felder-Puig, Gerald Gartlehner.   

Abstract

Nowadays the Randomised Controlled Trial (RCT) is seen as the gold standard for estimating the effectiveness of an observed intervention, achieving the highest hierarchy of evidence of primary research settings. Its study design basically includes two groups of patients, an intervention group and a control group; patients are randomly allocated to these two groups. After intervention or control intervention took place, predefined outcomes are quantified and compared in the two groups. The study design aims at eliminating all confounding and distorting factors (Bias and Confounder), so that different outcomes between the groups can be only explained by the intervention. There is a broad variation of quality of published RCTs. The reliability of results and extent to which findings provide a correct basis for generalisation to other circumstances needs to be validated. As part of a methods series of the Wiener Medizinische Wochenschrift this paper will discuss principles of study design, critical appraisal and limitations of RCTs.

Entities:  

Mesh:

Year:  2008        PMID: 18500478     DOI: 10.1007/s10354-008-0526-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  17 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 2.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

Review 3.  Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Authors:  J P Ioannidis; A B Haidich; M Pappa; N Pantazis; S I Kokori; M G Tektonidou; D G Contopoulos-Ioannidis; J Lau
Journal:  JAMA       Date:  2001-08-15       Impact factor: 56.272

Review 4.  A glossary for evidence based public health.

Authors:  Lucie Rychetnik; Penelope Hawe; Elizabeth Waters; Alexandra Barratt; Michael Frommer
Journal:  J Epidemiol Community Health       Date:  2004-07       Impact factor: 3.710

5.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

6.  A simple and valid tool distinguished efficacy from effectiveness studies.

Authors:  Gerald Gartlehner; Richard A Hansen; Daniel Nissman; Kathleen N Lohr; Timothy S Carey
Journal:  J Clin Epidemiol       Date:  2006-08-04       Impact factor: 6.437

Review 7.  Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology.

Authors:  Lawrence W Green; Russell E Glasgow
Journal:  Eval Health Prof       Date:  2006-03       Impact factor: 2.651

8.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.

Authors:  K F Schulz; D A Grimes; D G Altman; R J Hayes
Journal:  BMJ       Date:  1996-03-23

9.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

Review 10.  The rise and fall of menopausal hormone therapy.

Authors:  Elizabeth Barrett-Connor; Deborah Grady; Marcia L Stefanick
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

View more
  4 in total

Review 1.  [Pain registries and similar data collections : A systematic review].

Authors:  A Freytag; B Scriba; U Kaiser; W Meißner
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

2.  [Diagnostic studies].

Authors:  Rosemarie Felder-Puig; Philipp Mad; Gerald Gartlehner
Journal:  Wien Med Wochenschr       Date:  2009

Review 3.  Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19.

Authors:  Weilong Zhang; Yinghua Lv; Juan Yang; Yunhui Chen; Yingchun He; Jihan Huang
Journal:  Drug Des Devel Ther       Date:  2020-09-18       Impact factor: 4.162

Review 4.  Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov.

Authors:  Jihan Huang; Yingchun He; Qianmin Su; Juan Yang
Journal:  Drug Des Devel Ther       Date:  2020-05-29       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.